Equity-Based Compensation (Details) - Schedule of summarizes RSA and RSU activity shares in Thousands	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock Units, Units vested	1,897
Restricted Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock Units, Units nonvested, Beginning Balance	2,380
Restricted Stock Units, Units granted	5,448
Restricted Stock Units, Units cancelled	294
Restricted Stock Units, Units vested	2,548
Restricted Stock Units, Units nonvested, Ending Balance	4,986
Restricted Stock Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock Awards, Units nonvested, Beginning Balance	208
Restricted Stock Awards, Units granted	459
Restricted Stock Awards, Units cancelled
Restricted Stock Awards, Units vested	333
Restricted Stock Awards, Units nonvested, Ending Balance	334
Total Restricted Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Total Restricted Awards, Units nonvested, Beginning Balance	2,588
Total Restricted Awards, Units granted	5,907
Total Restricted Awards, Units cancelled	294
Total Restricted Awards, Units vested	2,881
Total Restricted Awards, Units nonvested, Ending Balance	5,320
Weighted-Average Grant-Date Fair Value [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Weighted-Average Grant-Date Fair Value, Units nonvested, Beginning Balance (in Dollars per share) | $ / shares	$ 7.61
Weighted-Average Grant-Date Fair Value, Units granted (in Dollars per share) | $ / shares	3.25
Weighted-Average Grant-Date Fair Value, Units cancelled | $ / shares	1.54
Weighted-Average Grant-Date Fair Value, Units vested (in Dollars per share) | $ / shares	6.2
Weighted-Average Grant-Date Fair Value, Units nonvested, Ending Balance (in Dollars per share) | $ / shares	$ 3.79